Free Trial

AbbVie (ABBV) SEC Filings & 10K Form

AbbVie logo
$189.60 +1.97 (+1.05%)
Closing price 07/8/2025 03:59 PM Eastern
Extended Trading
$190.50 +0.90 (+0.47%)
As of 05:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AbbVie SEC Filings

DateFilerForm TypeView
07/07/2025
12:20 PM
AbbVie (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
07/03/2025
12:07 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:04 PM
AbbVie (Issuer)
FALK THOMAS J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
Davis Jennifer L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
Hart Brett J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
MEYER MELODY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
Quaggin Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
Roberts Rebecca B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:05 PM
AbbVie (Issuer)
FALK THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
12:24 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
6:48 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:30 PM
AbbVie (Subject)
Stewart Jeffrey Ryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
6:40 PM
AbbVie (Filer)
Form ARS
03/24/2025
3:28 PM
AbbVie (Filer)
Form DEF 14A
03/24/2025
3:28 PM
AbbVie (Filer)
Form DEFA14A
03/18/2025
4:00 PM
AbbVie (Issuer)
Reents Scott T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:34 PM
AbbVie (Subject)
Reents Scott T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
4:05 PM
AbbVie (Filer)
Form PRE 14A
03/10/2025
3:28 PM
AbbVie (Issuer)
Purdue David Ryan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2025
4:57 PM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:37 PM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:00 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:00 PM
AbbVie (Issuer)
Buckbee Kevin K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:47 PM
AbbVie (Subject)
Buckbee Kevin K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
4:00 PM
AbbVie (Filer)
Form 424B5
02/19/2025
8:22 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
8:25 PM
AbbVie (Subject)
Form FWP
02/18/2025
7:41 AM
AbbVie (Filer)
Form 424B5
02/14/2025
12:17 PM
AbbVie (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
6:30 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
6:42 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:31 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:00 PM
AbbVie (Issuer)
Buckbee Kevin K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:34 PM
AbbVie (Subject)
Buckbee Kevin K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)

Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.

We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
11/04/2024
3:15 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
3:16 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
1:19 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:43 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:07 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
4:00 PM
AbbVie (Issuer)
Quaggin Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:00 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:00 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:00 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:06 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
2:30 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:40 PM
AbbVie (Subject)
Hudson Thomas J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:22 PM
AbbVie (Subject)
Hudson Thomas J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
2:00 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
9:54 AM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
6:41 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:40 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:17 PM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ABBV) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners